Nation has lots of expectations from CSIR labs : Dr N . Kalaiselvi
The CSIR-One Week One Lab program organized by CSIR-CDRI from 13th to 18th February concluded in the presence of Dr . N . Kalaiselvi , Director General , CSIR and Secretary DSIR , Govt . of India . The program was initiated with unveiling of the original foundation stone of CSIR-CDRI which was laid by Pt . Jawaharlal Nehru , then the Prime Minister of India on 17th February 1951 in the Chattar Manzil Palace . Now this foundation stone has shifted to Institute ’ s New campus . Dr . N Kalaiselvi addressed the scientists and researchers , motivating them to do their best irrespective to what capacity they are working for the organization . She interacted with the scientists and visited some important Laboratories & Facilities ( NMR , X- Ray , Electron Microscopy , CBRS , Herbarium ). To strengthen the Institutional-Academia and Institutional-Industry collaborations , two MoU was signed with Manipal Academy of Higher
Education , Manipal and another with Themis Medicare Limited , Mumbai .
IIT Guwahati researchers produce cardiac proteins to fix a damaged heart
A research team from Indian Institute of Technology Guwahati led by Dr . Rajkumar P . Thummer , Assistant Professor , Department of Biosciences & Bioengineering , along with his research scholar , Krishna Kumar Haridhasapavalan , have developed a ‘ Recombinant Protein Toolbox ’ comprising of six special proteins , which can be used to convert healthy skin cells or any somatic cells from an adult human body into heart cells , specifically cardiomyocytes . The heart cells created using this toolbox can have the same function as the original heart cells and can be used to regenerate damaged heart tissues . Importantly , this toolbox can facilitate the generation of autologous heart cells in a lab . It is now well understood that a heart attack happens when a part of the heart is damaged .
AstraZeneca ’ s Durvalumab receives CDSCO approval in India
AstraZeneca India , a leading science-led biopharmaceutical company has announced additional indication approval from Central Drugs Standard Control Organization ( CDSCO ) for
BioTech
BIOVOICENEWS . COM 9